2024-2025板块走势复盘:2024年上半年,CXO板块在美国生物安全法案事件催化、各企业业绩增速预期调整等因素的影响下继续走低;2024年9月,国内股市出现政策驱动性牛市、地缘风险短期出清,CXO板块股价同步上涨;2025年3月,部分CXO头部上市公司订单数据超预期,二级市场估值注入;2025年4月,特朗普政府关税政策的频繁变化对股市带来了短期扰动;2025年二、三季度,随短期扰动出清、(...
Source Link2024-2025板块走势复盘:2024年上半年,CXO板块在美国生物安全法案事件催化、各企业业绩增速预期调整等因素的影响下继续走低;2024年9月,国内股市出现政策驱动性牛市、地缘风险短期出清,CXO板块股价同步上涨;2025年3月,部分CXO头部上市公司订单数据超预期,二级市场估值注入;2025年4月,特朗普政府关税政策的频繁变化对股市带来了短期扰动;2025年二、三季度,随短期扰动出清、(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.